Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,103 recruiting studies in this area right now.
By phase
- Not applicable4,204
- Phase 2591
- Phase 1413
- Phase 3328
- Phase 4255
- Phase 1/Phase 2245
- Phase 2/Phase 367
Top conditions
- Ovarian Cancer338
- Cervical Cancer226
- Endometrial Cancer210
- Bladder Cancer187
- Acute Kidney Injury135
- Endometriosis132
- Pregnancy129
- Chronic Kidney Diseases123
- Breast Cancer111
- Chronic Kidney Disease108
- Infertility91
- Renal Cell Carcinoma80
- Colorectal Cancer78
- Preeclampsia71
- Prostate Cancer68
- Pregnancy Related65
- Hypertension59
- Urinary Incontinence59
Leading sponsors
- Mayo Clinic61
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS45
- M.D. Anderson Cancer Center45
- Assistance Publique - Hôpitaux de Paris44
- National Cancer Institute (NCI)41
- University of Colorado, Denver38
- AstraZeneca36
- University of Aarhus35
- Chinese University of Hong Kong34
Where studies are running
- California351
- Alabama154
- Texas118
- Massachusetts117
- New York117
- Arizona106
- Florida103
- Maryland87
- Colorado84
- Illinois79
Recruiting studies6,103 total
- NCT05279742Enrolling by invitationPhase 1/Phase 2
Study drug to boost a hormone system in HFpEF
This early-phase trial tests a treatment that aims to improve the “natriuretic peptide” hormone system in people with HFpEF (heart failure with preserved pumping strength). It may help reduce symptoms and improve heart and fluid pressure behavior, especially in certain related conditions like kidney disease.
Rochester, MinnesotaAges 18 years+ - NCT05283421Recruiting
Improving tests for abnormal cervical cells after menopause
This trial is looking at better ways to diagnose changes in the cervix in women after menopause. It may help by improving how doctors decide which cervical abnormalities need attention and follow-up.
RandersAges 50 years+ - NCT05263050RecruitingPhase 2
Trial tests a new cabozantinib schedule for kidney and neuroendocrine tumors
This Phase 2 study tests a different dosing schedule of cabozantinib (a cancer medicine) for metastatic kidney cancer and certain neuroendocrine tumors. It aims to see if the timing and schedule can work well for people with advanced disease.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05284552RecruitingPhase 2
Tinzaparin blood-thinner and biomarkers after ovarian cancer surgery
This Phase 2 study tests whether the blood thinner tinzaparin used after neoadjuvant treatment can change blood markers (“biomarkers”) in people with certain stages of ovarian cancer. It aims to understand if tinzaparin affects the body’s cancer-related signals, which could help future treatment decisions.
Eksjö, EksjöAges 18 years+ - NCT05297734Recruiting
Study compares two cancer support care plans
This study tests two different ways of providing supportive care for adults with cancer to see which one works better. It may help improve comfort, support, and care coordination during treatment.
Birmingham, AlabamaAges 18 years+ - NCT05285878Enrolling by invitationPhase 2
Fingolimod to protect kidney function after kidney transplant
This trial tests whether fingolimod can reduce kidney scarring and preserve kidney function after a new kidney transplant. It focuses on people who are in the early period after transplant who may be at risk for scarring in the kidney.
Houston, TexasAges 18–65 - NCT05286034Recruiting
AI chatbot to help women join cervical screening
This trial tests whether an AI chatbot can encourage women to take part in cervical cancer screening. It targets women who have not had a recent Pap test and who did not respond to an invitation letter, aiming to improve participation.
CarcassoneAges 30–65 - NCT05306925Recruiting
Arginine supplement study for newborns after major gut surgery
This study looks at whether giving an amino-acid supplement called arginine to newborns after major bowel surgery can improve the baby’s immune response. It may help doctors understand how to support recovery after conditions like necrotizing enterocolitis or certain birth defects.
Liverpool, MerseysideAges 5 months–10 months - NCT05258292Recruiting
Track blood sugar changes with your period in type 1 diabetes
This study monitors how your blood sugar (glucose) changes across your menstrual cycle using a continuous glucose monitor. It may help researchers understand patterns that could improve diabetes care around monthly hormonal changes.
Montreal, QuebecAges 18–50 - NCT05263076Recruiting
Uterus transplant trial for women born without a working uterus
This trial studies uterus transplant surgery to help people with “absolute uterine factor infertility” (no working uterus) become pregnant using embryos made by IVF. It checks whether the donated uterus can support pregnancy and safe delivery for participants who meet strict medical and health requirements.
Houston, TexasAges 20–65 - NCT05290129Recruiting
Oxytocin drip during C-section labor to help maintain contractions
This trial tests whether a continuous oxytocin infusion during a C-section helps maintain labor progress in people already receiving oxytocin. It may help reduce labor-related complications, but only if you meet the safety requirements for anesthesia and pregnancy conditions.
Toronto, OntarioAges 18–50 - NCT05268588Recruiting
Post-birth health texting study during late pregnancy
This study tests whether phone-based (mHealth) messages and support can improve health after you give birth. It may help you stay informed and get support during the weeks right after delivery.
Chandīgarh, HaryanaAges 18–49 - NCT05287321RecruitingPhase 3
Aspirin plus hydroxychloroquine to prevent preeclampsia in high-risk pregnancy
This trial tests whether adding aspirin and hydroxychloroquine can lower the risk of preeclampsia during pregnancy in people considered high-risk. If you qualify, you may be assigned to take the study medicines to help protect you and the baby.
SeoulAges 19–50 - NCT05269381RecruitingPhase 1/Phase 2
Personalized cancer vaccine with pembrolizumab for advanced solid tumors
This trial tests a personalized vaccine made from your tumor's unique markers, combined with the drug pembrolizumab, to help your immune system fight cancer. It is for people with advanced solid tumors who have already tried standard treatments.
Jacksonville, FloridaAges 16 years+ - NCT05277688RecruitingPhase 3
Radiation alone versus added chemotherapy after cervical cancer surgery
This trial compares standard radiation to radiation plus chemotherapy after surgery for early-stage cervical cancer. It aims to lower the chance the cancer comes back in patients considered higher risk based on their surgical pathology.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05264779Recruiting
Decision help tool for very early delivery planning
This study tests a decision-support tool (a structured way to guide conversations) for parents facing a high risk of delivering very early (about 22–26 weeks). It may help you and your baby’s care team make clearer, more aligned choices about neonatal (newborn) treatment.
San Diego, CaliforniaAges 18 years+ - NCT05273424Enrolling by invitation
Study of outcomes for people on long-term dialysis
This study looks at health outcomes for people living with chronic kidney disease who have been on hemodialysis for more than 90 days. It may help doctors better understand what to expect over time and how dialysis care can be improved in Brazil.
Pelotas, Rio Grande do SulAges 18 years+ - NCT05257746Recruiting
Testing bladder and rectal function after rectal surgery
This study follows people after rectal surgery to check how well the rectum and urinary (bladder) functions work over time. It may help doctors better understand recovery and what can improve quality of life after surgery.
Dresden, SaxonyAges 18 years+ - NCT05267626RecruitingPhase 1/Phase 2
AU-007 antibody for hard-to-remove or spread skin and lung cancers
This trial tests AU-007, an antibody that targets the IL-2 pathway, in people with certain advanced skin (melanoma) or lung (NSCLC) cancers. It’s designed for cancers that have already progressed after prior immune and other treatments, to see if AU-007 can shrink tumors or control disease.
Miami, FloridaAges 18 years+ - NCT05287945RecruitingPhase 1/Phase 2
Orellanine for kidney cancer patients on dialysis
This early-stage study tests orellanine to treat advanced kidney cancer that has spread (metastatic clear-cell or papillary type). It may help by shrinking or controlling cancer, and by seeing whether the treatment is safe and tolerable in people already on chronic dialysis.
Orange, CaliforniaAges 18 years+ - NCT05281471RecruitingPhase 3
Tested drug for platinum-resistant ovarian cancer with bevacizumab
This Phase 3 trial tests a treatment made of an investigational gene-based drug plus standard “platinum” chemotherapy and bevacizumab, compared with standard chemotherapy and bevacizumab. It’s for ovarian/fallopian tube/primary peritoneal cancers that have not responded to platinum chemotherapy or came back quickly.
Mobile, AlabamaAges 18 years+ - NCT05283330RecruitingPhase 1
Tested 212Pb imaging drug for certain advanced GRPR tumors
This early-phase study tests how safe and tolerable an experimental radiation drug is for adults with certain advanced or metastatic cancers that show a target called GRPR. Doctors will also use special scans to confirm the tumor has the target so the treatment can be delivered to the right place.
Chicago, IllinoisAges 18 years+ - NCT05264337Recruiting
Study for swelling after prostate or other urinary surgery
This study looks at swelling caused by lymph fluid buildup after urinary (urologic) surgery that removes lymph nodes. If you’re scheduled for or recently had this type of surgery, this trial may help researchers understand how to prevent or treat this swelling.
GothenburgAges 18 years+ - NCT02841553Recruiting
Online registry for Wolfram syndrome worldwide
This study builds an international online registry to learn how Wolfram syndrome (and related WFS1 conditions) changes over time. It may help researchers understand the disease course and improve future care by collecting health and family history data.
St Louis, MissouriAges birth+
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,103 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,012 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.